Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HAYNES, Andrew P")

Results 1 to 7 of 7

  • Page / 1
Export

Selection :

  • and

A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by RituximabDANIELS, Ian; TURZANSKI, Julie; HAYNES, Andrew P et al.British journal of haematology. 2008, Vol 142, Num 3, pp 394-403, issn 0007-1048, 10 p.Article

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphomaBISHTON, Mark J; HAYNES, Andrew P.British journal of haematology. 2007, Vol 136, Num 1, pp 111-113, issn 0007-1048, 3 p.Article

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcomeBARRANS, Sharon L; EVANS, Paul A. S; O'CONNOR, Sheila J. M et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2133-2139, issn 1078-0432, 7 p.Article

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphomaBARRANS, Sharon L; CARTER, Ian; OWEN, Roger G et al.Blood. 2002, Vol 99, Num 4, pp 1136-1143, issn 0006-4971Article

Mantle cell lymphoma in leukaemic phaseLUSH, Richard J; SOWTER, David P; HAYNES, Andrew P et al.British journal of haematology. 2002, Vol 117, Num 1, issn 0007-1048, p. 1Article

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaINGRAM, Wendy; DEVEREUX, Stephen; MUFTI, Ghulam J et al.British journal of haematology. 2008, Vol 141, Num 2, pp 235-243, issn 0007-1048, 9 p.Article

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsFAULKNER, Rowena D; CRADDOCK, Charles; MCQUAKER, Grant et al.Blood. 2004, Vol 103, Num 2, pp 428-434, issn 0006-4971, 7 p.Article

  • Page / 1